Here is my regulatory news blog for this week… Advanced Accelerator Applications received US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors  https://www.reuters.com/article/us-advanced-accelerator-fda/fda-approves-drug-for-rare-cancer-that-killed-steve-jobs-idUSKBN1FF29K The FDA’s Center for Biologics Evaluation and Research (CBER) unveiled the draft guidance documents it plans to publish in 2018, which will include as many as six documents on gene[…]